Skip to main content

Stonepine Capital Management, LLC

Position in EOLS — Evolus, Inc.

CIK 1440771 BEND, OR

Position in EOLS

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$7,229,864
-$3,620,196 QoQ
Shares Held
1,759,091
+7.8% QoQ
Ownership
2.67%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Derivatives in EOLS

reported options exposure · as of Mar 31, 2026
CallValue
$1,726,200
CallShares
420,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Stonepine Capital Management, LLC holds $10,499,486 across 4 Drug Manufacturers - Specialty & Generic names. EOLS ranks #1 (68.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EOLS
Evolus, Inc.
This page
1,759,091 $7,229,864

All Filings in EOLS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,229,864 1,759,091
2026-03-31 $1,726,200 420,000
2025-12-31 $10,850,060 1,631,588
2025-09-30 $9,433,440 1,536,391
2025-06-30 $8,440,965 916,500
2025-03-31 $13,648,925 1,134,574
2024-12-31 $13,961,747 1,264,651
2024-09-30 $22,191,100 1,369,821
2024-06-30 $17,985,079 1,657,611
2024-03-31 $37,440,984 2,674,356
2023-12-31 $56,156,532 5,333,004
2023-09-30 $47,336,096 5,179,004
2023-03-31 $4,896,605 578,795
2022-12-31 $6,266,584 834,432
2022-09-30 $1,610,000 200,000
2022-03-31 $6,577,433 586,224
2021-12-31 $12,128,754 1,863,096
2021-09-30 $2,286,000 300,000
2020-03-31 $3,415,284 822,960